Supply Chain Council of European Union | Scceu.org
News

Signant supply chain software offers end-to-end visibility

All the elements of a clinical trial supply chain are, as the name indicates, closely linked together. Intelligent management of vital study medications and supplies is a formidable challenge, and a misstep could mean cost overruns, trial delays, and failure to get patients the drugs when needed.

Oliver Cunningham, vice president of supplies management with Signant Health, discussed the complexities of clinical supply chain management, and one tech solution designed to help streamline the process.

OSP: Could you please talk about some of the biggest/most formidable challenges trial professionals face when managing clinical trial logistics?

OC: The biggest risk for a clinical supplies team is not having the right medication on time for patients enrolled in the clinical trial. This is largely due to the lack of supply chain visibility, leading to poor forecasting and planning for ongoing and future needs, both at the manufacturing (program) and site (study) level.

Because the risk of a missed patient is so high, clinical supply teams typically resort to creating buffers by ordering more drugs than needed to avoid stock out. However, the demand generated from site recruitment is often unpredictable, and stock is frequently unable to be transferred between sites, resulting in many sites throwing away excess and expired stock – a particular concern for high-cost products with a short shelf life. 

OSP: Similarly, what are some of the missteps (or maybe missed steps) logistics managers commonly make?

Related posts

The coronavirus is disrupting the global supply chain, starting with these commodities

scceu

Inflation, supply chain issues exacerbates need for Summer Meals for Kids program

scceu

Make your supply chain resilient with Sense.ai | Leadership

scceu